Myocardial Infarction Therapeutics Market

Myocardial Infarction
Therapeutics Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
sales@futuremarketinsights.com
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: hari.t@futuremarketinsights.com




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Myocardial infarction, generally called as heart attack is characterized by reduced blood
supply to the heart muscles, primarily due to coronary artery disease. According to
American Heart Association (AHA), every year around 17.3 Mn people die of heart
diseases worldwide, with myocardial infarction being the leading cause of death. In 2012,
British Heart Foundation reported 73,680 deaths in United Kingdom due to coronary
heart disease. Mortality from acute myocardial infarction can be decreased if patient
receives the emergency access to the treatment. The global cardiovascular treatment
market generated a revenue of 170 Bn in 2010 and is expected to expand drastically over
the forecast period of 2016-2026. Multitude of products available for the treatment of
acute myocardial infarction with different indications include Zorprin, Plavix, Angiomax,
Diovan, Lovenox, Aggrastat, NitroStat, Benicar and many more.
Myocardial Infarction Therapeutics Market: Drivers and Restraints
Increasing incidence of coronary artery disease and changes in lifestyle are the major
factors expected to drive the growth of global myocardial infarction therapeutics market.
Increasing number of smokers, increasing incidence of obesity and blood pressures, lack
of exercise can be some other reasons likely to flourish the global myocardial infarction
therapeutics market over the forecast period of 2016-2026. WHO findings show that the
death rate due to cardiovascular diseases is more in smokers than that in non-smokers.
Request free sample Report:
http://www.futuremarketinsights.com/reports/sample/rep-gb-1263
Report
Description
Report Description
Myocardial Infarction Therapeutics Market: Segmentation
The global myocardial infarction therapeutics market has been classified on the basis
product type, distribution channel and geography.
Based on product type, the global myocardial infarction therapeutics market is divided
into following:
• Analgesics
• Antiplatelet agents
• Vasodilators
• Thrombolytics and anti-thrombotic agents
• Glycoprotein IIb/IIIa inhibitors
• Β adrenergic blockers
• Angiotensin receptor antagonists
• Angiotensin converting enzyme inhibitors
Based on distribution channel, the global blood canner treatment market is divided into
following:
• Hospitals
Report
Description
Report Description
• Hospital Pharmacies
• Drug Stores
• Online drug stores
Myocardial Infarction Therapeutics Market: Overview
Analgesics and antiplatelet agents’ segments are foreseen to hold more share in global
myocardial infarction therapeutics market as these agents are used for initial treatment
of an acute myocardial infarction. Amongst sales channels, hospital pharmacy segment is
expected to contribute more into global myocardial infarction therapeutics market. The
global myocardial infarction therapeutics market is foreseen to experience the boost in
market volume over the forecast period due to the launch of several new products such
as Apixaban, Xarelto and introduction of generic drugs after expiration of patents for
Crestor and Benicar.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1263
Myocardial Infarction Therapeutics Market: Regional Overview
Geographically, the global myocardial infarction terapeutic market is classified into
regions namely, North America, Latin America, Western Europe, Eastern Europe, AsiaPacific, Japan, Middle East and Africa. North America will continue to take leading
position in global myocardial infarction therapeutic market owing to expanding aging
population and prevalence of co-morbidities.
Report
Description
Report Description
The expiry of blockbuster drugs in European market is likely to deter the segment share
in global myocardial infarction therapeutics market. Japan is expected to experience the
stagnancy in global myocardial infarction therapeutics market, in part due to saturation in
R&D.
Myocardial Infarction Therapeutics Market: Key Players
Some of the key players in global myocardial infarction therapeutics market are Novartis
N.V., Daiichi Sankyo Company Limited, Bristol-Myers Squibb Company, Boehringer
Ingelheim GmbH, AstraZeneca, Apotex Inc., Sandoz, Par Pharmaceutical Companies, Inc.,
Mylan N.V., Pfizer Inc.
Browse full report: http://www.futuremarketinsights.com/reports/myocardial-infarctiontherapeutics-market
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705